Sarepta Therapeutics Inc (NASDAQ:SRPT)
| 79.35 Delayed Data As of Jun 18 |  -0.74 / -0.92%Today’s Change | 67.68 Today|||52-Week Range 181.83 | -53.46% Year-to-Date |
Latest SRPT News | Press Releases
| Why Did the FDA Approve Biogen's Alzheimer's Disease Drug After an Advisory Panel Recommended Against It? Jun 18 / MotleyFool.com - Paid Partner Content | Nia Impact Advisors, Llc Buys Fortinet Inc, Maxeon Solar Technologies, Seagen Inc, Sells Seagen ... Jun 16 / GuruFocus News - Paid Partner Content |
Today’s Trading
| Previous close | 80.09 |
| Today’s open | 79.01 |
| Day’s range | 78.04 - 79.71 |
| Volume | 59,411 |
| Average volume (3 months) | 1,201,568 |
| Market cap | $6.3B |
Data as of 4:07pm ET, 06/18/2021
Growth & Valuation
| Earnings growth (last year) | +26.82% |
| Earnings growth (this year) | +6.26% |
| Earnings growth (next 5 years) | -44.40% |
| Revenue growth (last year) | +41.82% |
| P/E ratio | NM |
| Price/Sales | 24.61 |
| Price/Book | 8.27 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PRGOPerrigo Company PLC | -1.42 | -2.98% |
| ALLKAllakos Inc | +2.45 | +2.74% |
| TGTXTG Therapeutics Inc | -0.29 | -0.77% |
| IONSIonis Pharmaceutical... | +0.23 | +0.61% |
Data as of 4:00pm ET, 06/18/2021
Financials
| Next reporting date | August 11, 2021 |
| EPS forecast (this quarter) | -$1.30 |
| Annual revenue (last year) | $540.1M |
| Annual profit (last year) | -$554.1M |
| Net profit margin | -102.60% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
